A comparative study of mirabegron versus doxazosin in improving ureteral stent-related dysfunction

1

Ureteral stents are commonly used in urological procedures but can cause significant stent-related symptoms (SRS) affecting quality of life.
2

Doxazosin and mirabegron are medications used to alleviate SRS, with doxazosin being an alpha-blocker and mirabegron a β3-adrenergic receptor agonist.
3

This study aimed to compare the efficacy and side effects of mirabegron and doxazosin in improving ureteral stent symptoms, particularly sexual dysfunction.
4

The study was a double-blind, randomized trial conducted at Anning First People's Hospital, involving participants with ureteral stones.
5

Primary outcomes included pain during intercourse and sexual dissatisfaction, assessed using the Ureteral Stent Symptoms Questionnaire (USSQ).

World Journal Of Urology

1